Latest Breaking News On - Timothy lu - Page 2 : comparemela.com

Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical Program

Senti Bio Announces Strategic Steps to Prioritize Investment in Lead Clinical Program
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Timothy luSenti biosciences incSecurities exchangeDrug administrationExchange commissionBio announces strategic stepsPrioritize investmentLead clinicalGene circuitLogic gatedInvestigational new drugChief executive officerCelest therapeuticsSpark therapeuticsSenti bioGene circuits

Senti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia

– First patient in Phase 1 clinical trial expected to be treated in Q2 2024 – – Initial clinical efficacy data expected by year-end 2024 and durability data expected in 2025 – –.

United statesKanya rajangamTimothy luRon moldaverHead of research developmentExchange commissionSecurities exchangeSenti biosciences incDrug administrationLogic gated gene circuitsGene circuitInvestigational new drugChief executive officerLogic gatingChief medical officerSenti bio

Senti Biosciences, Inc : Senti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia

Senti Biosciences, Inc : Senti Bio Announces FDA Clearance of IND Application for SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesStefan klotterTimothy luRon moldaverKanya rajangamSenti biosciences incSecurities exchangeExchange commissionHead of research developmentDrug administrationLogic gated gene circuitsGene circuitInvestigational new drugChief executive officerLogic gatingChief medical officer

Senesco Technologies (SNTI) Announces FDA Clearance of IND Application for SENTI-202

Senesco Technologies (SNTI) Announces FDA Clearance of IND Application for SENTI-202
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesKanya rajangamTimothy luDrug administrationHead of research developmentSenti biosciences incSenti biosciencesInvestigational new drugChief executive officerGene circuitLogic gatingChief medical officerSenti bio

Senti Bio Announces New Strategic Collaboration with Celest Therapeutics for Clinical Development of SENTI-301A in China

Senti Bio Announces New Strategic Collaboration with Celest Therapeutics for Clinical Development of SENTI-301A in China
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Hong kongErdong huaTimothy luExchange commissionCelest therapeutics shanghai coSecurities exchangeLtd celestCelest therapeutics for clinical developmentCelest therapeuticsSenti biosciences incBio announces new strategic collaborationClinical developmentSenti bioGene circuitChief executive officerGene circuits